Health and Healthcare

Biogen : BIIB

All Biogen Articles

606 Articles

Chris Lange | Aug 26, 2020 at 10:13 AM EDT

Major Biotechs Scare Off Short Sellers

The August 14 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Aug 12, 2020 at 8:25 AM EDT

Short Sellers Shy Away From Big Biotech

The July 31 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Aug 7, 2020 at 10:51 AM EDT

Biogen Has Potentially Great News in the Fight Against Alzheimer’s

The world may be focused on COVID-19 this year, but the battle against Alzheimer’s disease continues with no effective treatments.…

Chris Lange | Aug 6, 2020 at 11:14 AM EDT

Denali Therapeutics Takes Next Big Step in Treating Parkinson’s

Denali Therapeutics announced early Thursday that it would be progressing its Parkinson’s treatment into late-stage studies in collaboration with Biogen.

Chris Lange | Jul 27, 2020 at 9:41 AM EDT

Big Biotechs Scare Off Short Sellers

The July 15 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Jul 27, 2020 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Albermarle, Biogen, D&B, eBay, First Solar, Lemonade, Morgan Stanley, P&G, Schlumberger, Verizon and More

Monday's top analyst upgrades and downgrades included Albermarle, Biogen, Dun & Bradstreet, eBay, First Solar, Lemonade, Morgan Stanley, Procter &…

Chris Lange | Jul 15, 2020 at 7:28 AM EDT

6 Warren Buffett Stocks That Could Soar as 2021 Approaches

24/7 Wall St. looks at some potential winners among Warren Buffett’s holdings. See why they could rally headed toward 2021…

Chris Lange | Jul 13, 2020 at 9:43 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Biotechs

The June 30 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | Jul 8, 2020 at 10:00 AM EDT

Biogen Could Still Have Massive Upside From Its Alzheimer’s Drug

Biogen may be on track to be one of the first companies with a meaningful treatment for Alzheimer’s disease, and…

Chris Lange | Jun 25, 2020 at 9:46 AM EDT

Short Sellers Run for Cover From Major Biotechs

The June 15 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Jun 22, 2020 at 9:07 AM EDT

Top Analyst Upgrades and Downgrades: Amex, Biogen, Discover, DraftKings, Ericsson, Foot Locker, Gap, Kraft Heinz, Nikola, Walmart, Zscaler and More

Monday's top analyst upgrades and downgrades included American Express, Biogen, Discover Financial, DraftKings, Ericsson, Foot Locker, Gap, Kraft Heinz, Nikola,…

Chris Lange | Jun 15, 2020 at 1:10 PM EDT

Canaccord Genuity’s Top Biopharma Catalysts for the Rest of 2020

Canaccord Genuity recently released a report detailing some of the biggest biotech catalysts coming out over these next six months.

Chris Lange | Jun 10, 2020 at 10:01 AM EDT

Major Biotechs Have Short Sellers on the Run

The May 29 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Jun 9, 2020 at 9:14 AM EDT

Top Analyst Upgrades and Downgrades: Avaya, Biogen, Broadcom, Chevron, Domino’s, eBay, MGIC, RealReal, Sprout Social, T-Mobile, Zoom, Zynga and More

Tuesday's top analyst upgrades and downgrades included Avaya, Biogen, Broadcom, Chevron, Domino's Pizza, eBay, MGIC Investment, RealReal, Sprout Social, T-Mobile,…

Chris Lange | May 28, 2020 at 9:37 AM EDT

Major Biotechs See More Targeted Short Sellers

The May 15 short interest data has been compared with the previous report, and short interest moves in these selected…

1 … 4 5 6 7 8 … 41

Biogen : BIIB

All Biogen Articles

Major Biotechs Scare Off Short Sellers

Short Sellers Shy Away From Big Biotech

Biogen Has Potentially Great News in the Fight Against Alzheimer’s

Denali Therapeutics Takes Next Big Step in Treating Parkinson’s

Big Biotechs Scare Off Short Sellers

Top Analyst Upgrades and Downgrades: Albermarle, Biogen, D&B, eBay, First Solar, Lemonade, Morgan Stanley, P&G, Schlumberger, Verizon and More

6 Warren Buffett Stocks That Could Soar as 2021 Approaches

Short Sellers Can’t Make Up Their Minds on Big Biotechs

Biogen Could Still Have Massive Upside From Its Alzheimer’s Drug

Short Sellers Run for Cover From Major Biotechs

Top Analyst Upgrades and Downgrades: Amex, Biogen, Discover, DraftKings, Ericsson, Foot Locker, Gap, Kraft Heinz, Nikola, Walmart, Zscaler and More

Canaccord Genuity’s Top Biopharma Catalysts for the Rest of 2020

Major Biotechs Have Short Sellers on the Run

Top Analyst Upgrades and Downgrades: Avaya, Biogen, Broadcom, Chevron, Domino’s, eBay, MGIC, RealReal, Sprout Social, T-Mobile, Zoom, Zynga and More

Major Biotechs See More Targeted Short Sellers

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Biogen : BIIB

All Biogen Articles

Major Biotechs Scare Off Short Sellers

Short Sellers Shy Away From Big Biotech

Biogen Has Potentially Great News in the Fight Against Alzheimer’s

Denali Therapeutics Takes Next Big Step in Treating Parkinson’s

Big Biotechs Scare Off Short Sellers

Top Analyst Upgrades and Downgrades: Albermarle, Biogen, D&B, eBay, First Solar, Lemonade, Morgan Stanley, P&G, Schlumberger, Verizon and More

6 Warren Buffett Stocks That Could Soar as 2021 Approaches

Short Sellers Can’t Make Up Their Minds on Big Biotechs

Biogen Could Still Have Massive Upside From Its Alzheimer’s Drug

Short Sellers Run for Cover From Major Biotechs

Top Analyst Upgrades and Downgrades: Amex, Biogen, Discover, DraftKings, Ericsson, Foot Locker, Gap, Kraft Heinz, Nikola, Walmart, Zscaler and More

Canaccord Genuity’s Top Biopharma Catalysts for the Rest of 2020

Major Biotechs Have Short Sellers on the Run

Top Analyst Upgrades and Downgrades: Avaya, Biogen, Broadcom, Chevron, Domino’s, eBay, MGIC, RealReal, Sprout Social, T-Mobile, Zoom, Zynga and More

Major Biotechs See More Targeted Short Sellers

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s